Equities analysts forecast that Markel Co. (NYSE:MKL) will report $1.58 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Markel’s earnings, with the lowest sales estimate coming in at $1.54 billion and the highest estimate coming in at $1.66 billion. Markel reported sales of $1.43 billion in the same quarter last year, which would suggest a positive year-over-year growth rate of 10.5%. The firm is expected to report its next earnings results on Wednesday, February 14th.

On average, analysts expect that Markel will report full year sales of $1.58 billion for the current year, with estimates ranging from $5.93 billion to $6.06 billion. For the next financial year, analysts expect that the company will post sales of $6.39 billion per share, with estimates ranging from $6.12 billion to $6.81 billion. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Markel.

Markel (NYSE:MKL) last issued its earnings results on Wednesday, October 25th. The insurance provider reported ($18.82) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($18.03) by ($0.79). Markel had a return on equity of 0.83% and a net margin of 1.60%.

MKL has been the topic of several analyst reports. SunTrust Banks reaffirmed a “hold” rating and issued a $1,100.00 target price on shares of Markel in a research report on Friday, October 27th. Royal Bank of Canada reaffirmed a “hold” rating and issued a $1,050.00 target price on shares of Markel in a research report on Tuesday, October 3rd. Zacks Investment Research lowered Markel from a “buy” rating to a “hold” rating in a research report on Thursday. Finally, Boenning Scattergood reaffirmed a “buy” rating on shares of Markel in a research report on Thursday, October 26th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Markel has a consensus rating of “Buy” and a consensus target price of $1,109.50.

Shares of Markel (NYSE MKL) opened at $1,123.37 on Monday. Markel has a 52-week low of $612.00 and a 52-week high of $1,157.30. The company has a quick ratio of 0.55, a current ratio of 0.55 and a debt-to-equity ratio of 0.28. The firm has a market capitalization of $15,605.86, a price-to-earnings ratio of 249.64 and a beta of 1.04.

In other Markel news, Director Lemuel E. Lewis purchased 1,000 shares of the stock in a transaction dated Wednesday, November 8th. The shares were bought at an average cost of $1,080.96 per share, with a total value of $1,080,960.00. Following the completion of the acquisition, the director now owns 5,294 shares of the company’s stock, valued at $5,722,602.24. The purchase was disclosed in a filing with the SEC, which is available through this link. Also, Vice Chairman Steven A. Markel sold 200 shares of the firm’s stock in a transaction on Thursday, October 26th. The shares were sold at an average price of $1,067.57, for a total value of $213,514.00. Following the transaction, the insider now directly owns 109,220 shares in the company, valued at $116,599,995.40. The disclosure for this sale can be found here. Insiders sold 2,307 shares of company stock worth $2,535,956 over the last ninety days. 2.53% of the stock is owned by corporate insiders.

Several institutional investors and hedge funds have recently modified their holdings of the company. Nisa Investment Advisors LLC increased its holdings in shares of Markel by 16.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 2,100 shares of the insurance provider’s stock valued at $2,392,000 after purchasing an additional 300 shares during the period. Simplex Trading LLC increased its holdings in shares of Markel by 169.1% during the fourth quarter. Simplex Trading LLC now owns 148 shares of the insurance provider’s stock valued at $168,000 after purchasing an additional 93 shares during the period. Parametric Portfolio Associates LLC increased its holdings in shares of Markel by 4.4% during the third quarter. Parametric Portfolio Associates LLC now owns 24,398 shares of the insurance provider’s stock valued at $26,057,000 after purchasing an additional 1,029 shares during the period. IFM Investors Pty Ltd acquired a new position in shares of Markel during the third quarter valued at $478,000. Finally, Stonebridge Capital Advisors LLC acquired a new position in shares of Markel during the third quarter valued at $219,000. 76.79% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “$1.58 Billion in Sales Expected for Markel Co. (MKL) This Quarter” was originally reported by American Banking News and is the sole property of of American Banking News. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.americanbankingnews.com/2018/01/15/1-58-billion-in-sales-expected-for-markel-co-mkl-this-quarter-2.html.

Markel Company Profile

Markel Corporation is a financial holding company serving a range of markets. The Company’s principal business markets and underwrites specialty insurance products. It monitors and reports its ongoing underwriting operations in three segments: U.S. Insurance, International Insurance and Reinsurance. The Company, through its subsidiary Markel Ventures, Inc (Markel Ventures), owns interests in various industrial and service businesses that operate outside of the specialty insurance marketplace.

Get a free copy of the Zacks research report on Markel (MKL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Markel (NYSE:MKL)

Receive News & Ratings for Markel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel and related companies with MarketBeat.com's FREE daily email newsletter.